A Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant Zoster Vaccine (CHO Cell)
Clinical trial NCT07293065 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07293065
- Sponsor
- MAXVAX Biotechnology Limited Liability Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-15
- Primary completion
- 2027-12-31
- Enrollment
- 12000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.